Broker Tips
Broker tips: Prudential, Victrex
JPMorgan Cazenove reiterated its ‘overweight’ rating on Prudential on Tuesday as it said concerns about the stock reflect fear rather than fundamentals.
Berenberg downgrades Victrex to 'hold' from 'buy'
Berenberg downgraded Victrex on Tuesday to ‘hold’ from ‘buy’ as it said the company’s performance in industrial-exposed sectors could remain subdued for longer than it previously expected.
JPMorgan reiterates ‘overweight’ rating on Prudential
JPMorgan Cazenove reiterated its ‘overweight’ rating on Prudential on Tuesday as it said concerns about the stock reflect fear rather than fundamentals.
Broker tips: Segro, Sage, CMC Markets
Citi upgraded Segro on Monday to ‘buy’ from ‘neutral’, saying it estimates that as rates decline, the risk to its previous estimates of deep recession rent declines reverses and it now expects growth.
Barclays downgrades Sage Group to ‘underweight’
Barclays downgraded Sage Group on Monday to ‘underweight’ from ‘equalweight’ and cut the price target to 985p from 1,050p.
Citi upgrades Segro to ‘buy’ from ‘neutral’
Citi upgraded Segro on Monday to ‘buy’ from ‘neutral’, saying it estimates that as rates decline, the risk to its previous estimates of deep recession rent declines reverses and it now expects growth.
CMC Markets' share-price rally isn't done yet, says RBC
RBC Capital Markets said it sees further upside at CMC Markets despite a near-50% jump in the stock over the past two months following a positive trading update from the online trading company.
JP Morgan backs Legal & General, Just Group
JP Morgan has reiterated its ratings on Legal & General Group and Just Group in its latest review of the UK life insurance sector.
Morgan Stanley double upgrades Persimmon to ‘overweight’
Morgan Stanley upgraded its stance on Persimmon on Friday as it took a look at the UK housebuilding sector.
RBC still sees significant upside at Hays despite Q2 weakness
RBC Capital Markets has trimmed its target price for recruitment firm Hays after last week's profit warning, but maintained an 'outperform' rating on the back of significant upside potential.
Broker tips: Yellow Cake, Informa
Analysts at Berenberg raised their target price on uranium group Yellow Cake from 744. 0p to 883. 0p on Thursday following a fireside chat with chief executive Andre Liebenberg and Dustin Garrow, managing principal at Nuclear Fuel Associates and chief commercial officer of 308 Services.
Re-rating at Informa "long overdue", says Bank of America
Bank of America has said it sees 40% upside in the share price of Informa after raising its target price for the publishing, business intelligence and exhibitions group on Thursday.
Berenberg raises target price on Yellow Cake
Analysts at Berenberg raised their target price on uranium group Yellow Cake from 744. 0p to 883. 0p on Thursday following a fireside chat with chief executive Andre Liebenberg and Dustin Garrow, managing principal at Nuclear Fuel Associates and chief commercial officer of 308 Services.
Broker tips: Drax, Midwich, Smith & Nephew, IMI
Citi downgraded Drax to 'sell' on Wednesday as it argued the shares have re-rated "unjustifiably" on the hope of further government support - a view the bank does not share before the general election.
Berenberg lowers target price on Midwich
Analysts at Berenberg lowered their target price on audio-visual distributor Midwich from 800. 0p to 710. 0p on Wednesday following the group's recent full-year trading update.
Citi downgrades Drax to 'sell'
Citi downgraded Drax to ‘sell’ on Wednesday as it argued the shares have re-rated "unjustifiably" on the hope of further government support - a view the bank does not share before the general election.
BofA Merrill Lynch lifts Smith & Nephew price target
Bank of America Merrill Lynch upped its price target on Smith & Nephew on Wednesday to 1,320p from 1,180p.
Goldman Sachs upgrades IMI to ‘buy’
Goldman Sachs upgraded shares of engineer IMI on Wednesday to ‘buy’ from neutral’ and lifted the price target to 2,020p from 1,780p, saying it sees around 30% upside versus 17% for the sector.
Broker tips: AstraZeneca, GSK, Persimmon, Crest Nicholson, Premier Foods, Rightmove, Moneysupermarket, Rolls-Royce
UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.
UBS downgrades AstraZeneca to 'sell'
UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.